Autophagy and Akt‐Stimulated Cellular Proliferation Synergistically Improve Antibody Production in CHO Cells
Biotechnology Journal · 2024
DOI: 10.1002/biot.202400033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von Leran Mao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Autophagy, Cricetulus, Cell Proliferation, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Project Award Agreement from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), U.S. Department of Commerce, National Institute of Standards and, Technology.
Abstract (Originalsprache)
Over the past decade, engineered producer cell lines have led 10‐fold increases in antibody yield, based on an improved understanding of the cellular machinery influencing cell health and protein production. With prospects for further production improvements, increased antibody production would enable a significant cost reduction for life‐saving therapies. In this study, we strategized methods to increase cell viability and the resulting cell culture duration to improve production lifetimes. By overexpressing the cell surface adenosine A 2A receptor (A 2A R), the Akt pathway was activated, resulting in improved cellular proliferation. Alternatively, by inducing autophagy through temperature downshift, we were able to significantly enhance cellular‐specific productivity, with up to a three‐fold increase in total antibody production as well as three‐fold higher cell‐specific productivity. Interestingly, the expression levels of the autophagy pathway protein Beclin‐1 appeared to correlate best with the total antibody production, of autophagy‐related proteins examined. Thus, during cell clonal development Beclin‐1 levels may serve as a marker to screen for conditions that optimize antibody titer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Leran Mao, Anne S Robinson
Förderung
- Project Award Agreement from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
- U.S. Department of Commerce, National Institute of Standards and
- Technology
Zitieren
APA
Mao, L., Sonbati, S. M., Schneider, J. W., & Robinson, A. S. (2024). Autophagy and Akt‐Stimulated Cellular Proliferation Synergistically Improve Antibody Production in CHO Cells. Biotechnology Journal. https://doi.org/10.1002/biot.202400033
Vancouver
Mao L, Sonbati SM, Schneider JW, Robinson AS. Autophagy and Akt‐Stimulated Cellular Proliferation Synergistically Improve Antibody Production in CHO Cells. Biotechnology Journal. 2024. doi:10.1002/biot.202400033
BibTeX
@article{Mao2024,
author = {Mao, Leran and Sonbati, Sarah Michelle and Schneider, James W and Robinson, Anne S},
title = {Autophagy and Akt‐Stimulated Cellular Proliferation Synergistically Improve Antibody Production in CHO Cells},
journal = {Biotechnology Journal},
year = {2024},
doi = {10.1002/biot.202400033}
}
EUVIMED